Table of contents

• BPH(Benign Prostatic Hyperplasia) at a Glance
• What Is Benign Prostatic Hyperplasia (BPH) Treatment?
• Who Is a Good Candidate for Benign Prostatic Hyperplasia (BPH) Treatment?
• How Is Benign Prostatic Hyperplasia (BPH) Treatment Performed?
• Why Visit Korea for Benign Prostatic Hyperplasia (BPH) Treatment?
• Key Information for International Patients
• Which Are the Best Clinics in Korea for Bphbenign Prostatic Hyperplasia?
• BPH(Benign Prostatic Hyperplasia) From Start to Finish
• Alternatives to Benign Prostatic Hyperplasia (BPH) Treatment
• How Can I Prepare for Benign Prostatic Hyperplasia (BPH) Treatment?
• Aftercare Advice

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

Last updated: September 2026

BPH(Benign Prostatic Hyperplasia) at a Glance

• Treatment is individualized — BPH treatment ranges from monitoring and medication to transurethral procedures such as TURP, HoLEP, Aquablation, Rezūm, or UroLift; the choice depends on prostate size and anatomy, obstruction, bladder function, complication history, anesthesia risk, and ejaculation priorities.
• Best candidates — Treatment is considered for urinary symptoms that disrupt daily life or persist despite medication, and needs prompt urology review for recurrent retention, infections, bladder stones, bleeding, upper-tract dilation, or kidney impairment linked to obstruction.
• Sexual-function tradeoff — TURP and HoLEP remove tissue and are generally durable but commonly cause retrograde ejaculation or markedly reduced semen volume, while selected UroLift, Rezūm, and Aquablation candidates may have better ejaculation-preservation potential.
• Recovery and results — Alpha-blockers can improve flow within days, while prostate-shrinking medicines usually take 3–6 months; after tissue-removing surgery, urinary burning, urgency, variable flow, and intermittent blood in urine can last days to weeks, with functional assessment most meaningful at 6–12 weeks.
• Korea travel planning — Allow 2–4 business days for consultation and testing, then plan about 10–14 days in Korea after uncomplicated endoscopic surgery for catheter management, voiding assessment, and surgeon review; 2–3 weeks may be needed for bleeding, infection, retention, or catheter dependence.
• Korean evidence — In a Korean nationwide claims cohort of 58,346 patients, HoLEP was associated with lower reoperation than TURP over about four years (1.27% versus 4.50%), but slightly more surgery for stress incontinence (0.31% versus 0.10%); these are population-level associations, not proof of superior results at every hospital.
• Important safety check — Urinary symptoms should not be assumed to be BPH: infection, urethral stricture, bladder dysfunction, medication effects, and prostate cancer can look similar, so suspicious PSA, examination, or imaging findings need appropriate evaluation before irreversible treatment.

What Is Benign Prostatic Hyperplasia (BPH) Treatment?

Benign prostatic hyperplasia (BPH) treatment refers to care for noncancerous prostate enlargement that can obstruct urine flow. It aims to ease urinary symptoms, improve bladder emptying, and prevent problems such as urinary retention or recurrent infections. Treatment may be non-surgical, minimally invasive, or surgical, depending on symptoms, prostate features, overall health, and personal priorities.

Who Is a Good Candidate for Benign Prostatic Hyperplasia (BPH) Treatment?

• Bothersome urinary symptoms — Good candidates have weak or intermittent flow, hesitancy, straining, incomplete emptying, urgency, frequency, urge leakage, or nocturia that affects sleep, work, or daily life.
• Confirmed obstruction or enlarged prostate — Assessment supports BPH or benign prostatic obstruction through symptom scoring, urine testing, uroflowmetry, post-void residual measurement, and prostate imaging as appropriate.
• Medication failure or intolerance — Intervention is often considered when alpha-blockers such as tamsulosin, alfuzosin, or silodosin do not provide acceptable relief, or when finasteride, dutasteride, tadalafil, or combination treatment is unsuitable or unwanted.
• BPH-related complications — Recurrent urinary retention, recurrent infection, bladder stones, persistent bleeding attributed to BPH, overflow incontinence, upper-tract dilation, or obstruction-related renal impairment warrant prompt urology review.
• Clear priorities for sexual function and durability — The choice between tissue-removing surgery and ejaculation-preserving approaches depends on prostate size, median-lobe anatomy, retention history, bladder function, and the importance of preserving antegrade ejaculation.

BPH is non-cancerous prostate growth, but urinary symptoms must not be assumed to be BPH. Urinary infection, urethral stricture, neurogenic bladder, medication effects, poor bladder-muscle function, and prostate cancer can produce similar symptoms; BPH and prostate cancer can also coexist. PSA elevation, an abnormal rectal examination, or suspicious imaging requires appropriate cancer evaluation before irreversible treatment. Elective urinary instrumentation or surgery should be deferred for untreated symptomatic infection, fever, uncorrected bleeding risk, or unoptimized anesthesia, heart, lung, kidney, or metabolic risk. Anticoagulants and antiplatelet medicines require a written plan from the prescribing clinician, anesthesiologist, and urologist; never stop them independently.

How Is Benign Prostatic Hyperplasia (BPH) Treatment Performed?

BPH treatment ranges from observation and medication to office-based procedures and endoscopic surgery. The best method is determined by symptom burden, prostate volume and shape, obstruction severity, bladder function, retention or infection history, bleeding risk, anesthesia fitness, and priorities around ejaculation and retreatment.

• Observation and medication — Mild, non-bothersome symptoms without complications can be monitored. Alpha-blockers relax the prostate and bladder neck and often improve flow within days; 5-alpha-reductase inhibitors shrink enlarged prostates and reduce progression risk over 3–6 months. Tadalafil can suit selected men who also have erectile dysfunction.
• Bipolar TURP — Transurethral resection removes obstructing tissue through the urethra and provides tissue for pathology. It remains a reference operation for many moderate-size obstructing prostates, but retrograde ejaculation or greatly reduced semen volume is common.
• HoLEP — Holmium laser enucleation separates the obstructing inner prostate tissue, which is then morcellated in the bladder. It is an established durable option across prostate sizes, including large glands, but depends substantially on surgeon experience and can cause temporary stress leakage.
• Laser vaporization or vaporesection — GreenLight and related transurethral laser techniques vaporize or remove tissue. Suitability, pathology yield, amount of tissue removed, and retreatment profile differ from enucleation.
• Aquablation — An ultrasound-guided robotic waterjet removes tissue transurethrally under anesthesia, followed by bleeding control. It can be relevant when ejaculation preservation is a high priority, but suspected prostate cancer should be evaluated before treatment because it does not produce intact resected tissue for pathology. See Aquablation in Korea.
• UroLift and Rezūm — UroLift uses permanent implants to hold lateral prostate tissue apart, while Rezūm uses steam injections that ablate tissue gradually. Both are anatomy-dependent, and Rezūm often involves temporary catheterization and delayed improvement. See UroLift in Korea and Rezūm treatment in Korea.
• PAE or simple prostatectomy — Prostate artery embolization requires multidisciplinary and anatomy-based selection. Open or robotic simple prostatectomy is generally reserved for very large prostates when endoscopic enucleation is unavailable or unsuitable.

Why Visit Korea for Benign Prostatic Hyperplasia (BPH) Treatment?

Korea has published national administrative-data research on BPH surgery and recent local comparative research on newer transurethral techniques. This supports the presence of established TURP, HoLEP, and Aquablation practice, but it does not prove that every hospital offers every technology or has equivalent outcomes. Confirm the proposed procedure, surgeon-specific experience, and English-language follow-up pathway directly with the treating institution.

• National comparative data — A Korean nationwide reimbursement-database cohort of 58,346 patients treated from 2011–2017 found lower reoperation in the HoLEP group than the TURP group over roughly four years of mean follow-up (1.27% versus 4.50%). Surgery for stress incontinence was uncommon but more frequent after HoLEP (0.31% versus 0.10%); these are population-level associations from claims data, not a surgeon-level causal comparison.
• Documented technique trends — Korean national-system data have described BPH surgery use by technique, region, age, and hospital type. However, administrative coding cannot fully capture prostate anatomy, baseline symptoms, ejaculation outcomes, learning curves, or all complications.
• Recent local Aquablation evidence — A Yonsei University retrospective study of 104 patients treated in 2023–2024 found symptom and residual-urine improvement after both Aquablation and HoLEP. HoLEP produced greater flow-rate and PSA reduction, while Aquablation preserved ejaculation better in a limited sexually active subgroup; the single-center study had small matched groups and only about 10–11 months of follow-up, so it is not Korea-wide proof of superiority.
• Questions worth asking — Request prostate-volume and median-lobe eligibility, the surgeon's case experience with the exact technique, catheter and anesthesia pathway, pathology handling, and outcome data with denominators for transfusion, return to theatre, continence, ejaculation, readmission, and retreatment.

Key Information for International Patients

• Minimum stay — Allow 2–4 business days for consultation and testing when records are complete and a plan can be finalized promptly. For uncomplicated transurethral surgery, plan to remain in Korea about 10–14 days after the operation for early recovery, catheter removal or a documented catheter plan, voiding assessment, and surgeon review.
• Longer-stay factors — Plan 2–3 weeks when hematuria continues, retention recurs, a catheter remains necessary, infection develops, significant medical conditions need monitoring, or the return journey is long.
• Flight clearance — There is no universal fitness-to-fly interval for TURP, HoLEP, or Aquablation. The operating urologist must assess bleeding, urine drainage, infection, mobility, catheter needs, anesthesia recovery, venous-thromboembolism risk, and flight duration before clearing travel.
• Long-haul flight risk — Surgery and prolonged travel both increase clot risk. The CDC's 10-day no-fly advice specifically concerns chest or abdominal surgery, not transurethral prostate surgery; obtain individualized advice on walking, hydration, compression, and clot prevention when additional risk factors exist. See the CDC's medical-tourism guidance.
• Itinerary impact — Expect urinary urgency, burning, frequency, variable stream, and intermittent blood in urine for days to weeks after tissue-removing surgery. Avoid scheduling strenuous sightseeing, cycling, heavy luggage handling, or isolated travel during the early recovery period.
• Records and remote care — Bring English urology notes, PSA results with dates, imaging, MRI, biopsy or pathology reports, urine cultures, catheter history, medication and allergy lists, and relevant cardiology or anesthesia records. Before leaving Korea, obtain English copies of the operative report, discharge summary, pathology report if tissue was removed, medication list, and test results.

Travel note: Arrange local urology follow-up before returning home. Confirm in writing who will manage catheter problems, urine cultures, prescription refills, bleeding, and pathology or PSA discussions after travel.

Which Are the Best Clinics in Korea for Bphbenign Prostatic Hyperplasia?

Listed below are some of the best clinics in Korea for bphbenign prostatic hyperplasia.

1. Stantop Urology & Andrology

For benign prostatic hyperplasia (BPH), you can access prostate-focused evaluation and treatment at StanTop Urology & Andrology Clinic, including medication, minimally invasive procedures, and surgery intended to relieve symptoms related to an enlarged prostate. The clinic also offers a one-day prostate check-up that includes PSA testing and a digital rectal examination.

• URL: Stantop Urology & Andrology Website
• Location: Seoul
• BPH care:
  • Treatment options listed include medication, minimally invasive procedures, and surgery for enlarged-prostate symptoms.
  • Your treatment approach can be selected after prostate assessment rather than assuming one option suits every situation.
• Prostate evaluation:
  • A one-day prostate check-up is available.
  • The check-up includes PSA testing and a digital rectal examination.
  • Prostatitis diagnosis and treatment are also listed among the clinic’s prostate services.
• Privacy and clinic setting:
  • Separate consultation and treatment rooms are provided for men and women.
  • The clinic states that it has conducted more than 100,000 consultations and 40,000 surgeries.

2. Proud Urology Clinic

Proud Urology Clinic’s supplied information does not identify evaluation or treatment for benign prostatic hyperplasia (BPH), so you should confirm directly whether it provides care for urinary symptoms or an enlarged prostate before relying on it for this procedure.

• URL: Proud Urology Clinic Website
• Location: Seoul
• Listed urology services:
  • The available information focuses on men’s enhancement procedures, erectile-dysfunction surgery, premature-ejaculation treatment, vasectomy and reversal, circumcision, and reconstructive procedures.
  • STD/STI testing and treatment and HPV vaccination are also listed.
• Clinic information:
  • The clinic was established in 2016.
  • Its supplied profile states that it has JCI accreditation.

3. GoldMan Urology Clinic - Gangnam

For benign prostatic hyperplasia (BPH), GoldMan Urology Clinic - Gangnam lists tailored treatment options designed around your individual needs, with an emphasis on urological care and postoperative satisfaction. The supplied information does not specify the exact BPH techniques, so you can clarify which options are appropriate for your symptoms and prostate evaluation.

• URL: GoldMan Urology Clinic - Gangnam Website
• Location: Seoul
• BPH approach:
  • The clinic lists tailored treatment options for benign prostate hyperplasia.
  • Its stated approach emphasizes individual patient needs and optimal outcomes.

BPH(Benign Prostatic Hyperplasia) From Start to Finish

1. Remote inquiry and records review — Send English medical records, symptom history, medication and allergy lists, PSA results, imaging, urine cultures, retention or catheter history, and any biopsy or pathology reports. Confirm whether an English-speaking or virtual consultation is available and ask which tests must be repeated after arrival.
2. Urology consultation — The urologist reviews lower urinary tract symptoms, quality-of-life impact, sexual-function priorities, medical conditions, medicines, prior treatment, and the possibility of non-BPH causes of obstruction or urinary symptoms.
3. Diagnostic evaluation — Assessment commonly includes the International Prostate Symptom Score (IPSS), urinalysis, PSA when it will change management, uroflowmetry, post-void residual measurement, and prostate or urinary-tract imaging. Cystoscopy, urodynamics, renal testing, MRI, and biopsy are used selectively rather than automatically, consistent with EAU diagnostic guidance.
4. Treatment selection and travel coordination — The team matches the method to prostate size, median lobe, obstruction, bladder function, bleeding risk, anesthesia fitness, and the tradeoff between durability and ejaculation preservation. Confirm hospital stay, catheter plan, companion support, expected review date, flexible return flights, and remote follow-up before proceeding.
5. Preoperative checks — The hospital completes medication reconciliation, anesthesia assessment, urinalysis or culture when indicated, and blood tests such as complete blood count, renal function, and coagulation studies when clinically required. Active infection or uncontrolled bleeding risk must be addressed before surgery.
6. Anesthesia and treatment — TURP, HoLEP, laser surgery, and Aquablation are transurethral treatments: instruments pass through the urethra, without an external abdominal incision. Anesthesia type, operating time, bleeding-control method, and whether tissue is collected for pathology depend on the selected technique and anatomy.
7. Catheter, recovery, and discharge — A urinary catheter is commonly used after tissue-removing surgery and is removed after urine drainage and bleeding are acceptable. Discharge follows clinical stability, pain control, a successful voiding trial, or a clearly documented catheter-removal and repeat-voiding plan.
8. Surgeon review and overseas follow-up — Attend the scheduled postoperative review before flying. After returning home, arrange local urology care and remote contact with the Korean treating service for recurrent bleeding, infection, voiding difficulty, catheter issues, medication questions, pathology discussion, and longer-term symptom assessment.

Alternatives to Benign Prostatic Hyperplasia (BPH) Treatment

The central tradeoff is between the durability and tissue removal of surgery versus the lower immediate invasiveness and greater ejaculation-preservation potential of selected minimally invasive options. Less invasive treatment is not automatically safer or suitable for every anatomy, and it can involve delayed benefit, temporary catheterization, or a higher chance of later retreatment.

Medication Management

• Best suited to — Mild to moderate symptoms, patients without obstruction-related complications, or those who want to defer an intervention.
• Key tradeoff — Alpha-blockers can work quickly but do not remove tissue; finasteride and dutasteride require months and can cause sexual side effects. Medication is not an adequate substitute for urgent assessment of recurrent retention, infection, stones, upper-tract dilation, or obstruction-related renal impairment.

Aquablation

• Best suited to — Selected patients who need transurethral treatment and place high value on ejaculation preservation.
• Key tradeoff — It is performed under anesthesia and requires postoperative bleeding management. It does not provide intact resected tissue for pathology. Read about Aquablation in Korea.

Rezūm

• Best suited to — Selected anatomy and patients seeking a less invasive thermal option, including some median-lobe cases.
• Key tradeoff — Improvement develops as treated tissue is absorbed rather than immediately; temporary catheterization is common. Read about Rezūm treatment in Korea.

UroLift

• Best suited to — Selected patients with suitable lateral-lobe anatomy who prioritize rapid recovery and preservation of ejaculation.
• Key tradeoff — Permanent implants do not remove tissue. Median lobe, prostate size, retention history, and future retreatment risk require individualized discussion. Read about UroLift in Korea.

HoLEP or TURP

• Best suited to — Patients who want established tissue-removing treatment, have clear obstruction, or have larger glands or complications that make minimally invasive options less appropriate.
• Key tradeoff — These operations are generally more durable but commonly cause retrograde ejaculation or markedly reduced semen volume, and recovery requires catheter and bleeding monitoring.

How Can I Prepare for Benign Prostatic Hyperplasia (BPH) Treatment?

• Send complete records early — Provide urology notes, IPSS results if available, PSA trend, prostate imaging, MRI, biopsy or pathology reports, urine cultures, catheter history, medication and allergy lists, and relevant heart, lung, kidney, diabetes, or anesthesia records.
• Disclose all medicines and supplements — Report anticoagulants, antiplatelets, diabetes medicines, GLP-1 drugs, prescription erectile-dysfunction medicines, opioids, fish oil, vitamin E, ginkgo, garlic supplements, and herbal products. Do not start, stop, or bridge anticoagulants or antiplatelets without explicit written instructions from the prescribing clinician, anesthesiology team, and urologist.
• Complete infection checks — Provide recent urine results and report burning, fever, chills, cloudy urine, catheter blockage, or recent antibiotic use. Elective urinary surgery is usually postponed for untreated symptomatic urinary infection or systemic illness.
• Follow fasting instructions exactly — Anesthesia-directed fasting and medication instructions take priority. Ask how to take blood-pressure medicine, insulin, other diabetes drugs, and essential prescriptions on the morning of treatment.
• Avoid smoking and alcohol — Stop smoking as far in advance as the surgical team advises and avoid alcohol before anesthesia. Do not drink alcohol while taking opioid or sedating pain medicine after surgery.
• Plan transport and support — Book accommodation close enough for an easy return to the hospital. Arrange a responsible adult companion for the first 24–48 hours after anesthesia and for catheter care, mobility limits, language barriers, or a long transfer; do not drive after anesthesia or while using opioids.
• Keep flights flexible — Do not book a fixed early long-haul return. Build in at least 10–14 days after uncomplicated endoscopic surgery and longer when catheter dependence, bleeding, infection, or medical comorbidity is present.

Travel note: Carry medical documents in hand luggage, know where urgent urologic care is available near your accommodation, and ensure travel insurance covers planned treatment and complications.

Confirm the treating hospital's exact testing, fasting, medication, catheter, and travel requirements; individualized instructions take precedence over this general guidance.

Aftercare Advice

Protect urine drainage, avoid strain, and treat fever, clot retention, or inability to urinate as urgent problems after transurethral BPH treatment.

• Catheter and urination — Follow the hospital's catheter-care, fluid-intake, medication, and voiding-trial instructions exactly. Seek prompt help for a blocked catheter, poor drainage, complete inability to urinate, or worsening lower-abdominal pain.
• Bleeding and urinary symptoms — Burning, urgency, frequency, intermittent blood in urine, and a fluctuating stream can continue for days to weeks after TURP-like surgery. Contact the clinic urgently for heavy bright-red bleeding, clots with poor drainage, increasing bleeding, fever, chills, or worsening pain.
• Activity and sexual restrictions — Walk gently and increase activity gradually, but avoid strenuous exercise, heavy lifting, cycling, and sexual activity until surgeon clearance. For TURP-like surgery, this is often around 4–6 weeks; recovery can take longer with retention, poor bladder function, infection, bleeding, a catheter, or other medical conditions.
• Hydration, bowel care, and alcohol — Follow the surgeon's fluid target, prevent constipation and straining, and avoid alcohol while using sedating analgesics. Reducing evening caffeine, alcohol, and fluids can help urgency or nocturia for some people once the team confirms it is appropriate.
• Flight and clot symptoms — Do not fly until the operating urologist clears travel. Seek emergency care for chest pain, shortness of breath, coughing blood, or one-sided leg swelling, particularly after surgery or long-distance travel.
• Follow-up and results — Keep the surgeon review before departure and arrange local urology follow-up after return. Functional assessment is generally more meaningful at 6–12 weeks, although medication response and recovery timelines differ by treatment.

Follow the treating doctor's individualized instructions over general timelines, and contact the clinic promptly when urine flow, bleeding, pain, fever, or catheter function appears abnormal.